Acceleron Pharma Inc. [XLRN] to Ring The NASDAQ Stock Market Closing Bell
ADVISORY, Nov. 4, 2013 (GLOBE NEWSWIRE) --
Acceleron Pharma Inc. [XLRN], a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics to improve the lives of patients with cancer and rare diseases, will visit the NASDAQ MarketSite in Times Square.
- Acceleron completed a successful IPO in September 2013 which raised net proceeds of approximately $97M.
- Acceleron has three protein therapeutics being studied in 12 ongoing phase 2 clinical trials.
- Acceleron is developing two of its clinical programs (sotatercept and ACE-536) in a joint collaboration with partner Celgene [CELG] for the treatment of anemia in patients with rare blood diseases.
- Acceleron expects to present interim clinical results from its ongoing phase 2 clinical trial of sotatercept in patients with beta-thalassemia in early December at the American Society of Hematology's Annual Meeting.
- Acceleron will announce its third quarter 2013 financial results on Wednesday, November 6th at 9:00 AM.
In honor of the occasion, John Knopf, CEO will ring the Closing Bell. Dr. Knopf will be joined by the Acceleron management team, employees, colleagues and friends to celebrate the occasion.
NASDAQ MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Tuesday, November 5, 2013 – 3:45 p.m. to 4:00 p.m. ET
Maureen L. Suda (Media)
Suda Communications LLC
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
Facebook and Twitter:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ.
For news tweets, please visit our Twitter page at: http://twitter.com/nasdaqomx.
A live webcast of the NASDAQ Closing Bell will be available at: http://www.nasdaq.com/about/marketsitetowervideo.asx.
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About Acceleron Pharma Inc. [XLRN]:
Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases. The company is a leader in understanding the biology of the Transforming Growth Factor-Beta (TGF-β) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body, and in targeting these pathways to develop important new medicines. Acceleron has built a highly productive R&D platform that has generated innovative clinical and preclinical protein therapeutic candidates with novel mechanisms of action. These protein therapeutic candidates have the potential to significantly improve clinical outcomes for patients with cancer and rare diseases.
About NASDAQ OMX Group:
The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 26 markets including 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-55 microsecond average speeds with 99.99% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world's securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,300 listed companies worth $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn more, visit www.nasdaqomx.com. Follow us on Facebook (http://www.facebook.com/NASDAQ) and Twitter (http://www.twitter.com/nasdaqomx). (Symbol: NDAQ and member of S&P 500)
In This StoryNDAQ
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.